Figure 4 | Scientific Reports

Figure 4

From: CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making

Figure 4

(a) In the TCGA cohort the distribution of TCGA RNA-expression subtypes significantly differs according to CDKN2A copy number status (Chi2 0.016). (b) Vice versa there were significant differences in the CDKN2A expression in these subtypes (bas squam = basal squamous, lum = luminal, lum inf = luminal infiltrated, lum pap = luminal papillary, neur = neuronal). Of the analyzed, typically subtype defining, genes, KRT20, GATA3 and FOXA1 showed a differing expression in the CDKN2A expression groups (ce). (*p < 0.05; **p < 0.01; ***p < 0.001).

Back to article page